Skip to main content.
kumc.edu
Home

Pooja Bhadbhade, DO

Pooja Bhadbhade portrait
Associate Professor, Allergy, Clinical Immunology, and Rheumatology

Professional Background

I graduated medical school from Kansas City University of Medicine and Biosciences Osteopathic medical school. I then completed my internal medicine residency at the University of Kansas Medical Center, followed by my fellowship in Rheumatology at the University of Kansas Medical Center. I currently practice at the University of Kansas Medical Center as an Adult Rheumatologist and help train the rheumatology fellows. I also work with first and second year medical students once a week. I have particular interest in inflammatory arthritis, musculoskeletal ultrasound and procedures.

Education and Training
  • DO, Doctor of Osteopathic Medicine , Kansas City Univ of Med&BioSci, KANSAS CITY, Missouri
  • Clinical Fellowship, Rheumatology , University of Kansas Medical Center , Kansas City, KS
  • Internship, Internal Medicine , University of Kansas Medical Center , Kansas City, KS
  • Residency, Internal Medicine , University of Kansas Medical Center , Kansas City, KS
Licensure, Accreditations & Certifications
  • Musculoskeletal Ultrasound Certification in Rheumatology - RhMSUS, University of Kansas Medical Center
  • Rheumatology Certification Exam, American Board of Internal Medicine
  • USSONAR, The Ultrasound School of North American Rheumatologists
Professional Affiliations
  • American College of Rheumatology Member, American College of Rheumatology (ACR), Member, 2015 - Present
Selected Publications
  • Bhadbhade Pooja, Noaiseh Ghaith. 2020. Crystal Arthropathies. Cecil Essentials of Medicine 10e
  • O'Connor Patrick, Bhadbhade Pooja, Pritchett Michael, Laury Raquele, Sami Farhad, Amos Jonathon, Sharma Priyanka, Williamson Stephen. 2020. Acral vascular syndrome during an immune checkpoint inhibitor. BMJ Case Reports, 13 (5)
  • Medcalf Matthew, Bhadbhade Pooja, Mikuls Ted R, O'Dell James R, Gundry Rebekah L, Funk Ryan S. 2021. Plasma Metabolome Normalization in Rheumatoid Arthritis Following Initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy. Metabolites, 11 (12)
  • Medcalf Matthew, Bantis Leonidas, Shi Peng, Bhadbhade Pooja, Gundry Rebekah, Mikuls Ted, England Bryant, O'Dell James R, Funk Ryan. 2022. Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 56
  • Smolen Josef, Feist Eugen, Fatenejad Saeed, Grishin Sergey, Korneva Elena, Nasonov Evgeniy, Samsonov Mikhail, Fleischmann Roy, CREDO Group. 2022. Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis . The New England Journal of Medicine, 715-726. https://www-nejm-org.kumc.idm.oclc.org/doi/pdf/10.1056/NEJMoa2201302
  • Kumar Amar, Arain Mudassar Iqbal, Bhadbhade Pooja, Funk Ryan. 2023. Erythrocyte Folyl Polyglutamate Synthetase Activity Profiling as a Potential Tool for the Prediction of Methotrexate Efficacy and Toxicity in Rheumatoid Arthritis. Future Pharmacology, 3 (4), 819-833